Geode Capital Management, LLC Renovo Rx, Inc. Transaction History
Geode Capital Management, LLC
- $1.26 Trillion
- Q4 2024
A detailed history of Geode Capital Management, LLC transactions in Renovo Rx, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 235,748 shares of RNXT stock, worth $238,105. This represents 0.0% of its overall portfolio holdings.
Number of Shares
235,748
Previous 232,937
1.21%
Holding current value
$238,105
Previous $246,000
36.99%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding RNXT
# of Institutions
21Shares Held
2MCall Options Held
0Put Options Held
0-
Bank Of The West975KShares$984,7500.27% of portfolio
-
Adar1 Capital Management, LLC Austin, TX197KShares$199,2220.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA141KShares$142,9010.0% of portfolio
-
Nixon Peabody Trust CO Boston, MA97.2KShares$98,1360.01% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny76.8KShares$77,5820.0% of portfolio
About RenovoRx, Inc.
- Ticker RNXT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 9,066,860
- Market Cap $9.16M
- Description
- RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. RenovoRx, In...